Molecular Resistance Mechanisms of Macrolide-Resistant Invasive Streptococcus pneumoniae Isolates from Alaska, 1986 to 2010

Arctic Investigations Program, Centers for Disease Control and Prevention, 4055 Tudor Centre Drive, Anchorage, Alaska 99508, USA.
Antimicrobial Agents and Chemotherapy (Impact Factor: 4.48). 08/2013; 57(11). DOI: 10.1128/AAC.00319-13
Source: PubMed


Rapid emergence of antibiotic resistant pneumococcal strains has reduced treatment options. The aim of this study was to determine antimicrobial susceptibilities, serotype distributions and molecular resistance mechanisms among macrolide resistant invasive pneumococcal isolates in Alaska from 1986-2010. We identified cases of invasive pneumococcal disease in Alaska from 1986-2010 through statewide population-based laboratory surveillance. All invasive pneumococcal isolates submitted to the Arctic Investigations Program laboratory were confirmed by standard microbiological methods and serotyped by slide agglutination and the Quellung reaction. Minimal inhibitory concentrations were determined by the broth microdilution method and macrolide resistant genotypes determined by multiplex PCR. Among 2923 invasive pneumococcal isolates recovered from 1986-2010, 270 (9.2%) were non-susceptible to erythromycin; 177 (66%) erythromycin non-susceptible isolates demonstrated co-resistance to penicillin and 167 (62%) were multidrug resistant. The most frequent serotypes among the macrolide-resistant isolates were 6B (23.3%), 14 (20.7%), 19A (16.7%), 9V (8.9%), 19F (6.3%), 6A (5.6%) and 23F (4.8%). Mef and ermB genes were detected in 207 (77%) and 32 (12%) of isolates, respectively. Nineteen (7%) of the erythromycin non-susceptible isolates contained both mef and ermB genotypes; 15 were serotype 19A. There was significant year-to-year variation in the proportion of isolates that were non-susceptible to erythromycin (p<0.001).Macrolide resistance among pneumococcal isolates from Alaska is predominantly mediated by mef genes and this has not changed significantly over time. However, there was a statistically significant increase in the proportion of isolates that possess both ermB and mef, primarily due to serotype 19A isolates.

Download full-text


Available from: Karen M Rudolph, Dec 17, 2014
1 Follower
18 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background This study investigated the molecular characteristics of azithromycin-resistant Streptococcus pneumoniae in Taiwan.MethodsA total of 486 non-duplicate isolates of azithromycin-resistant S. pneumoniae recovered from various clinical sources of patients treated at 22 different hospitals in Taiwan from 2006 to 2010. The presence of erm(B) and mef(A) genes using duplex PCR, multilocus sequence typing (MLST), and pulsed-field gel electrophoresis of these isolates were studied.ResultsOf the isolates tested, 59% carried the erm(B) gene, 22% carried the mef(A) gene, and 19% carried both genes. The prevalence of isolates carrying the erm(B) and mef(A) genes increased from 10% (11/110) in 2006 to 25% (15/60) in 2010 (p-value¿=¿0.0136). The majority of isolates carrying both erm(B) and mef(A) genes belonged to serotypes 19 F (64%) followed by 19 F A (24%). Of these isolates, 33% were sequence type 320 (ST320), 32% were ST236, and 12% were ST271.Conclusions The increase in incidence of mef(A)/erm(B)-positive azithromycin-resistant S. pneumoniae isolates during the study period was primarily due to serotypes 19 F and 19A and ST236 and ST320.
    BMC Infectious Diseases 12/2014; 14(1):704. DOI:10.1186/s12879-014-0704-z · 2.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Broad-range 16S ribosomal RNA gene PCR coupled with Sanger sequencing was originally employed by soil scientists and was subsequently adapted for clinical applications. PCR coupled with electrospray ionization mass spectrometry has also progressed from initial applications in the detection of organisms from environmental samples into the clinical realm and has demonstrated promise in detection of pathogens in clinical specimens obtained from patients with suspected infection but negative cultures. We review studies of multiplex PCR, 16S ribosomal RNA gene PCR and sequencing and PCR coupled with electrospray ionization mass spectrometry for detection of bacteria in specimens that were obtained from patients during or after administration of antibiotic treatment, and examine the role of each for assisting in antimicrobial treatment and stewardship efforts. Following an exploration of the available data in this field, we discuss the opportunities that the preliminary investigations reveal, as well as the challenges faced with the implementation of these strategies in clinical practice.
    Expert Review of Molecular Diagnostics 12/2014; 15(3):1-12. DOI:10.1586/14737159.2015.989216 · 3.52 Impact Factor